Learn more about how Disarm Therapeutics and the Quanterix Accelerator Lab are powering biomarker testing for axonal degeneration. For more information: https://go.quanterix.com/simoaservices
Videos and Recordings
February 14, 2020
February 12, 2020
An informative panel from the 2019 Global Peter Drucker Forum featuring Quanterix Chairman and CEO, Kevin Hrusovsky. In a vast and complex ecosystem like health care, seemingly modest tweaks can produce far-ranging consequences—while attempts at large-scale change bog down and go nowhere.
January 17, 2020
In this conversation with Anne Mostue, Quanterix Chairman and CEO, Kevin Hrusovsky highlights 2019 successes and plans for the future.
January 16, 2020
Quanterix CEO Kevin Hrusovsky presents at the 38th Annual J.P Morgan Healthcare Conference. Access the Webcast and Q&A
October 08, 2019
Our CEO Kevin Hrusovsky joined Lyanne Alfaro on set of Nasdaq's
Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur of the Year® 2019 award winner in New England - Video Montage.
June 28, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chairman and CEO of Quanterix, and Founder of Powering Precision Health (PPH), has been